The Maturation of Myeloma Cells Correlates with Sensitivity to Chemotherapeutic Agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Maturation of Myeloma Cells Correlates with Sensitivity to Chemotherapeutic Agents

Published:2005-05-01 Issue:4 Volume:81 Page:335-341
ISSN:0925-5710
Container-title:International Journal of Hematology
language:
Short-container-title:International Journal of Hematology

Author:

Kuroda Yoshiaki,Sakai Akira,Okikawa Yoshiko,Munemasa Shoso,Katayama Yuta,Hyodo Hideo,Imagawa Jun,Takimoto Yasuo,Okita Hajime,Ohtaki Megu,Kimura Akiro

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://www.springerlink.com/index/pdf/10.1532/IJH97.04189

Reference16 articles.

1. Moreau P, Facon T, Leleu X, et al. Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy. Blood. 2002;100:1579-1583.

2. Greipp PR, Raymond NM, Kyle RA, O'Fallon WM. Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood. 1985;65:305-310.

3. Greipp PR, Leong T, Bennett JM, et al. Plasmablastic morphology-- an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group. Blood. 1998;91:2501-2507.

4. Huang N, Kawano MM, Harada H, et al. Heterogeneous expression of a novel MPC-1 antigen on myeloma cells: possible involvement of MPC-1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells. Blood. 1993;82:3721-3729.

5. Kawano MM, Huang N, Harada H, et al. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood. 1993;82:564-570.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial pyruvate carrier 1: a novel prognostic biomarker that predicts favourable patient survival in cancer;Cancer Cell International;2021-05-31

2. The clinical significance of CD49e and CD56 for multiple myeloma in the novel agents era;Medical Oncology;2020-10-17

3. MPC-1 expression in myeloma cells is associated with the efficacy of bortezomib therapy;Medical Oncology;2019-07-24

4. Clinical effects of CD33 and MPC-1 on the prognosis of multiple myeloma treated with bortezomib;Leukemia & Lymphoma;2019-03-19

5. DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma;Journal of Hematology & Oncology;2017-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3